IN8bio, Inc. Company Information

IN8bio, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: IN8bio, Inc.
  • Ticker: INAB
  • Exchange: NasdaqGM
  • Founded: 2016
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$22.020m
  • Shares Outstanding: 72.48m
  • Website: https://in8bio.com

Number of Employees


Location

  • IN8bio, Inc.
  • 350 5th Avenue
  • Suite 5330
  • New York
  • New York
  • 10118
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
6JHDB (Deutsche Boerse AG)YesCommon SharesDEEURJul 2021
INABNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJul 2021
6JHMUN (Boerse Muenchen)YesCommon SharesDEEURJul 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/26 11:15
End of Day Share Price 2024/11/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.